Tolvaptan, neprilysin inhibitors, sodium-glucose cotransporter-2 (SGLT2) inhibitors, and ivabradine have all been utilized at our center with varying effects to treat refractory heart failure symptoms. Here, SLC5A2 is linked to heart failure.